Glenmark Pharmaceuticals to conduct phase III trial on nasal spray

09 Jul 2021 Evaluate

Glenmark Pharmaceuticals is planning to conduct phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19. The company had sought emergency approval for import and marketing of the nasal spray from the drug regulator last week. However, the subject expert committee (SEC) under the drug regulator recommended Glenmark to conduct the Phase III trial. The Glenmark Company has joined hands with Canadian company Sanotize.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1992.70 -8.35 (-0.42%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×